Clinical trial
Sleep Apnea: Mechanism and Cerebrovascular Consequences
NCT00108602 · US Department of Veterans Affairs, U.S. Fed · Withdrawn
Key facts
| NCT number | NCT00108602 |
|---|---|
| Title | Sleep Apnea: Mechanism and Cerebrovascular Consequences |
| Official title | Sleep Apnea: Mechanism and Cerebrovascular Consequences |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Sleep Apnea, Obstructive, Stroke |
| Intervention type | Drug |
| Interventions | acetazolamide |
| Enrollment | 0 |
| Start date | May 1, 2007 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Apr 18, 2005 |
| Last update posted | Jun 26, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: